Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-028869
Filing Date
2022-03-02
Accepted
2022-03-01 19:48:26
Documents
4
Effectiveness Date
2022-03-02

Document Format Files

Seq Description Document Type Size
1 S-8 tm227647d1_s8.htm S-8 41170
2 EXHIBIT 5.1 tm227647d1_ex5-1.htm EX-5.1 5543
3 EXHIBIT 23.1 tm227647d1_ex23-1.htm EX-23.1 2220
4 EX-FILING FEES tm227647d1_ex-filingfee.htm EX-FILING FEES 30613
  Complete submission text file 0001104659-22-028869.txt   80559
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263194 | Film No.: 22700693
SIC: 2834 Pharmaceutical Preparations